Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1397)	3/3/2000 11:59:00 AM
From: RWReeves	Read Replies (1) \| Respond to of 2344

Not short BIOM. Not short anything in this market. I have followed Biomira since 1987 when I worked for another Canadian biotech. Would love to see BIOM skyrocket, but just page back a few on this thread and you see the same type of hopeful discussion when BIOM was stuck between 3 and 5. Trying to figure out what it is worth relative to the PERCEIVED value the market places on immunotherapeutics. Please don't get caught in the "If ARIA is worth 45, BIOM is worth x " game. There's momo and there's value. You can make a lot of money on either one and I try not to confuse the two. RWR